These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 11090078)

  • 1. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
    Smith KS; Rhee JW; Cleary ML
    Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.
    Romagnoli R; Baraldi PG; Prencipe F; Lopez-Cara C; Rondanin R; Simoni D; Hamel E; Grimaudo S; Pipitone RM; Meli M; Tolomeo M
    Eur J Med Chem; 2016 Jan; 108():39-52. PubMed ID: 26629859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
    Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
    Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.
    Harb JG; Neviani P; Chyla BJ; Ellis JJ; Ferenchak GJ; Oaks JJ; Walker CJ; Hokland P; Roy DC; Caligiuri MA; Marcucci G; Huettner CS; Perrotti D
    Leukemia; 2013 Oct; 27(10):1996-2005. PubMed ID: 23670294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
    Bellodi C; Lidonnici MR; Hamilton A; Helgason GV; Soliera AR; Ronchetti M; Galavotti S; Young KW; Selmi T; Yacobi R; Van Etten RA; Donato N; Hunter A; Dinsdale D; TirrĂ² E; Vigneri P; Nicotera P; Dyer MJ; Holyoake T; Salomoni P; Calabretta B
    J Clin Invest; 2009 May; 119(5):1109-23. PubMed ID: 19363292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.
    Lidonnici MR; Corradini F; Waldron T; Bender TP; Calabretta B
    Blood; 2008 May; 111(9):4771-9. PubMed ID: 18227349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
    Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
    Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells.
    Corradini F; Bussolari R; Cerioli D; Lidonnici MR; Calabretta B
    Blood Cells Mol Dis; 2007; 39(3):292-6. PubMed ID: 17644012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.
    Sillaber C; Mayerhofer M; Agis H; Sagaster V; Mannhalter C; Sperr WR; Geissler K; Valent P
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):485-504. PubMed ID: 13677268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor.
    Ghaffari S; Jagani Z; Kitidis C; Lodish HF; Khosravi-Far R
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6523-8. PubMed ID: 12750477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase cleavage enhances the apoptosis-inducing effects of BAD.
    Condorelli F; Salomoni P; Cotteret S; Cesi V; Srinivasula SM; Alnemri ES; Calabretta B
    Mol Cell Biol; 2001 May; 21(9):3025-36. PubMed ID: 11287608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects.
    Salomoni P; Condorelli F; Sweeney SM; Calabretta B
    Blood; 2000 Jul; 96(2):676-84. PubMed ID: 10887134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.
    Skorski T; Wlodarski P; Daheron L; Salomoni P; Nieborowska-Skorska M; Majewski M; Wasik M; Calabretta B
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11858-62. PubMed ID: 9751755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Wasik M; Trotta R; Kanakaraj P; Salomoni P; Antonyak M; Martinez R; Majewski M; Wong A; Perussia B; Calabretta B
    Blood; 1998 Jan; 91(2):406-18. PubMed ID: 9427693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of chronic myeloid leukemia.
    Maru Y
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation.
    CirinnĂ  M; Trotta R; Salomoni P; Kossev P; Wasik M; Perrotti D; Calabretta B
    Blood; 2000 Dec; 96(12):3915-21. PubMed ID: 11090078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant.
    Salomoni P; Wasik MA; Riedel RF; Reiss K; Choi JK; Skorski T; Calabretta B
    J Exp Med; 1998 Jun; 187(12):1995-2007. PubMed ID: 9625759
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.